908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors

BOSTON -- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Dr. Brandi Vann to serve on its Board of Directors. During more than 15 years at the U.S. Department of Defense (DoD), Dr. Vann held several leadership positions overseeing nuclear, chemical, and biological defense [...]

Pablo Perversi to Join METTLER TOLEDO Board of Directors

COLUMBUS, Ohio -- Mettler-Toledo International Inc. (NYSE: MTD) announced today that Pablo Perversi has been appointed to its Board of Directors, effective November 6, 2025. Mr. Perversi is the President of Europe at Danone, a leading global food and beverage company, and a member of its Executive Committee. Prior to his current role, Pablo served [...]

MaxCyte Signs Platform License Agreement with Adicet Bio

MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support development of Adicet’s gamma delta T cell therapy gene edited programs ROCKVILLE, Md -- MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics, today announced it has signed a strategic platform license [...]

Gatan launches the EDAX Orbis II Micro-XRF system

PLEASANTON, CA – Gatan, Inc., a business of AMETEK, Inc. as well as a global leader focused on enhancing and extending the operation and productivity of electron microscopes, has launched the EDAX® Orbis™ II System, designed to support a wide range of non-destructive elemental analysis that use micro x-ray fluorescence (micro-XRF). The Orbis II System directly addresses two [...]

Danaher Appoints Jonathan Leiken as General Counsel

WASHINGTON -- Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Jonathan Leiken has been appointed Senior Vice President and General Counsel, effective August 25, 2025. Mr. Leiken will report directly to President and Chief Executive Officer Rainer Blair and will serve as an executive officer and a member of the Danaher Leadership Team. Jonathan [...]

Thermo Fisher Scientific introduces Applied Biosystems™ MagMAX™ HMW DNA Kit, Helping Streamline Genomics Research and Oncology Discoveries

CARLSBAD, Calif. Image                 Overview:                                  Thermo Fisher Scientific has introduced the Applied Biosystems™ MagMAX™ HMW DNA Kit, providing a streamlined manual and automated extraction workflow to enable the reproducible isolation of High Molecular Weight (HMW) DNA suitable for long-read sequencing.   Engineered [...]

MaxCyte Announces Strategic Platform Licensing Agreement with Anocca AB to Advance TCR-T Cell Therapy Pipeline

MaxCyte’s Flow Electroporation® Technology will support non-viral gene editing in the manufacture of Anocca’s TCR-T cell therapies ROCKVILLE, Md. -- MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics, today announced the signing of a Strategic Platform License Agreement (SPL) [...]

ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota’s Center for Genome Engineering

ST. PAUL, Minn. -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that three investigators at the University of Minnesota's Center for Genome Engineering have been awarded $665,000 of G-Rex® Grant funding. Dr. Branden Moriarity, Associate Professor at the University of Minnesota, Co-Director of Center for Genome Engineering, Co-Director [...]

Instem achieves a major milestone, acquires all shares of Xybion from Banerjee Group LLC controlled by Dr. Pradip K. Banerjee

BOSTON & STAFFORDSHIRE, England -- Instem today announced the closing of an acquisition of Xybion Digital ("Xybion"). Xybion is best known for its PristimaTM preclinical study management platform. Like Instem, Xybion has primarily focused on serving life sciences customers, particularly CROs, Pharmas, and Biotechnology firms. Xybion was founded in 1977 to support preclinical R&D and drug [...]

Astrotech Subsidiary 1st Detect Announces First Tracer 1000 NTD System Sale in Vietnam

AUSTIN, Texas  -- Astrotech Corporation (Nasdaq: ASTC), a provider of next generation security screening and detection technologies based on Mass Spectrometry (“Mass Spec”), today announced the first sale and deployment of its TRACER 1000™ Narcotics Trace Detector (“TRACER 1000 NTD™”) in Vietnam, by way of its subsidiary 1st Detect. This milestone marks a significant step in expanding the [...]

Access IBO on Knowledge Center